Covered recipient · General Payments record
KRISTINA K GLICK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,385.70
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $594.38 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $164.27 | 11 |
| Lilly USA, LLC | $82.99 | 5 |
| DEXCOM, INC. | $54.69 | 3 |
| GlaxoSmithKline, LLC. | $53.88 | 2 |
| Otsuka America Pharmaceutical, Inc. | $41.26 | 2 |
| Gilead Sciences, Inc. | $38.33 | 2 |
| Exact Sciences Corporation | $35.06 | 2 |
| Lundbeck LLC | $33.13 | 2 |
| PFIZER INC. | $28.44 | 1 |
| Supernus Pharmaceuticals, Inc. | $26.85 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $20.02 | 1 |
| Novo Nordisk AS | $15.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.13 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227908 | CMS |
| ABBVIE INC. | $11.67 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227910 | CMS |
| ABBVIE INC. | $19.25 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227912 | CMS |
| ABBVIE INC. | $13.87 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227914 | CMS |
| ABBVIE INC. | $11.15 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227916 | CMS |
| ABBVIE INC. | $19.44 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227918 | CMS |
| ABBVIE INC. | $28.95 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227920 | CMS |
| ABBVIE INC. | $9.28 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227922 | CMS |
| ABBVIE INC. | $1.55 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227924 | CMS |
| ABBVIE INC. | $11.22 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227926 | CMS |
| ABBVIE INC. | $27.76 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107227928 | CMS |
| Dexcom, Inc. | $14.52 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153372791 | CMS |
| Dexcom, Inc. | $20.81 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153372793 | CMS |
| Dexcom, Inc. | $19.36 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153372795 | CMS |
| Exact Sciences Corporation | $16.61 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114482554 | CMS |
| Exact Sciences Corporation | $18.45 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114482560 | CMS |
| Gilead Sciences, Inc. | $19.57 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133651566 | CMS |
| Gilead Sciences, Inc. | $18.76 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133651568 | CMS |
| GlaxoSmithKline, LLC. | $31.87 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116184444 | CMS |
| GlaxoSmithKline, LLC. | $22.01 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116309637 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $20.02 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146242329 | CMS |
| Lilly USA, LLC | $14.18 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135762269 | CMS |
| Lilly USA, LLC | $15.07 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135803628 | CMS |
| Lilly USA, LLC | $16.07 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135784038 | CMS |
| Lilly USA, LLC | $18.96 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135750189 | CMS |
| Lilly USA, LLC | $18.71 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135803630 | CMS |
| Lundbeck LLC | $14.81 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146026852 | CMS |
| Lundbeck LLC | $18.32 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146026854 | CMS |
| Novo Nordisk Inc | $15.46 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100451924 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.02 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119080618 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.24 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119080620 | CMS |
| PFIZER INC. | $28.44 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131269572 | CMS |
| Supernus Pharmaceuticals, Inc. | $26.85 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147895529 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.